---
title: "Luoman Technologies released its first-quarter performance, with a net profit attributable to the parent company of 14.4164 million yuan, a year-on-year decrease of 20.68%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237692295.md"
description: "Luoman Technologies released its Q1 2025 performance report, with operating revenue of 180 million yuan, a year-on-year increase of 49.44%. However, the net profit attributable to shareholders of the listed company was 14.4164 million yuan, a year-on-year decrease of 20.68%; the net profit after deducting non-recurring gains and losses was 14.3626 million yuan, a year-on-year decrease of 22.59%. The basic earnings per share were 0.13 yuan/share"
datetime: "2025-04-27T08:29:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237692295.md)
  - [en](https://longbridge.com/en/news/237692295.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237692295.md)
generator: "portal-rs"
---

# Luoman Technologies released its first-quarter performance, with a net profit attributable to the parent company of 14.4164 million yuan, a year-on-year decrease of 20.68%

According to the Zhitong Finance APP, Luoman Technologies (605289.SH) released its first-quarter report for 2025, with operating revenue of 180 million yuan in the first quarter, a year-on-year increase of 49.44%; net profit attributable to shareholders of the listed company was 14.4164 million yuan, a year-on-year decrease of 20.68%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 14.3626 million yuan, a year-on-year decrease of 22.59%; basic earnings per share were 0.13 yuan/share

### Related Stocks

- [605289.CN](https://longbridge.com/en/quote/605289.CN.md)

## Related News & Research

- [Ships adopt makeshift anti-drone defences as Black Sea attacks intensify](https://longbridge.com/en/news/297784645.md)
- [Redstone launches EUR 10 million North Karelia Growth Fund II for early-stage startups, Business Joensuu says](https://longbridge.com/en/news/297465528.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)
- [Pegasus cancels overnight Russia flights Sept. 1-2 on technical, operational reasons](https://longbridge.com/en/news/297766590.md)
- [EXCLUSIVE-CIA-backed investor helped top German drones firm break into US](https://longbridge.com/en/news/297464128.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**